TRIB3 gene expression, in contrast to TRIB3 protein expression [85], has been shown to correlate with poor prognosis in patients with breast cancer [86] and a poor prognosis in patients with non-small cell lung cancer (NSCLC) [87]. This evidence concerns the gene TRIB3 and non-small cell lung carcinoma.